組織と腫瘍におけるデノボおよびセーバージュ purin 合成経路

Diem H Tran¹, Dohun Kim¹, Rushendhiran Kesavan¹

¹Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

Cell

|June 1, 2024

まとめ

細胞はニュクレオチドを作るために新たに保存経路を使用しますこの研究では,循環するアデニンとイノシンはプーリンを効果的に供給し,プーリンの回収を阻害すると腫瘍の成長が遅くなる.

科学分野:

生物化学
分子生物学
癌代謝

背景:

ピューリンヌクレオチドはDNA/RNAの合成,シグナル伝達,およびエネルギーに不可欠である.
細胞は purin 合成のために de novo と salvage の経路を利用する.
増殖する細胞は主にデノボ合成を使用すると考えられ,分化組織は救済を好む.

研究の目的:

循環中の purin 前駆体の in vivo 役割を調査する.
腫瘍における de novo と salvage 経路の貢献を比較する.
腫瘍の成長に対する purin 代謝の影響を決定する.

主な方法:

マウスでの定量代謝分析
purin 前駆体 (アデニン,イノシン,ヒポキサンチン) の投与
ピューリンの回収経路の阻害

主要な成果:

アデニンとイノシンは,循環するピュリンの有効な源であり,ヒポキサンチンは保存されがちです.
新しい経路と救出経路の両方が腫瘍のピュリンプールに寄与する.
ニュクレオチドの補充は腫瘍の成長を加速させる.
腫瘍の進行を遅らせます腫瘍の進行を遅らせます

結論:

循環中のピュリン前駆体は,体内での利用が異なる.
ピューリンの回収経路は腫瘍代謝において重要な役割を果たします
ピューリンの回収をターゲットにすることで癌の潜在的治療戦略を提示します

キーワード:

癌の代謝 de novo ピューリンの合成 in vivo 同位体追跡ニュクレオチドダイエット核酸代謝ピューリン基ピューリンの分解ピューリンの回収組織腫瘍の成長

さらに関連する動画

14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

20.2K

10:38

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

3.4K

関連する概念動画

01:38

Nucleotide Excision Repair

3.5K

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

3.5K

01:14

Drug Metabolism: Phase II Reactions

3.8K

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...

3.8K

01:19

Interactions Between Signaling Pathways

6.3K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

6.3K

02:56

Treatment Resistant Cancers

3.3K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.3K

01:02

Long-patch Base Excision Repair

7.0K

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

7.0K

01:54

Base Excision Repair

22.3K

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...